THER
Price:
$0.0001
Market Cap:
$615.15K
Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. The company through its patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. The company's data-generating assays provide actionable inform...[Read more]
Industry
Biotechnology
IPO Date
2010-04-01
Stock Exchange
PNK
Ticker
THER
According to Theralink Technologies, Inc.’s latest financial reports and current stock price. The company's current ROE is -41.95%. This represents a change of 2.61% compared to the average of -1.55% of the last 4 quarters.
The mean historical ROE of Theralink Technologies, Inc. over the last ten years is 102.95%. The current -41.95% ROE has changed -140.75% with respect to the historical average. Over the past ten years (40 quarters), THER's ROE was at its highest in in the August 2015 quarter at 475.53%. The ROE was at its lowest in in the December 2020 quarter at -609.58%.
Average
102.95%
Median
109.80%
Minimum
-189.76%
Maximum
335.41%
Discovering the peaks and valleys of Theralink Technologies, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 168.00%
Maximum Annual ROE = 335.41%
Minimum Annual Increase = -370.08%
Minimum Annual ROE = -189.76%
Year | ROE | Change |
---|---|---|
2023 | 81.09% | -75.82% |
2022 | 335.41% | 16.67% |
2021 | 287.49% | -251.50% |
2020 | -189.76% | -370.08% |
2019 | 70.26% | -181.98% |
2018 | -85.71% | -161.88% |
2017 | 138.52% | -43.14% |
2016 | 243.59% | -236.60% |
2015 | -178.33% | -154.54% |
2014 | 326.95% | 168.00% |
The current ROE of Theralink Technologies, Inc. (THER) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
234.66%
5-year avg
116.90%
10-year avg
102.95%
Theralink Technologies, Inc.’s ROE is less than Adhera Therapeutics, Inc. (0%), less than GB Sciences, Inc. (13.30%), less than SciSparc Ltd. (27.88%), greater than Creative Medical Technology Holdings, Inc. (-87.48%), greater than Regen BioPharma, Inc. (-58.37%), less than Enzolytics Inc. (16.82%), less than Sonnet BioTherapeutics Holdings, Inc. (93.13%), greater than Inhibikase Therapeutics, Inc. (-398.33%), greater than Sio Gene Therapies Inc. (-194.17%), greater than Kaleido Biosciences, Inc. (-13.69%), less than Tempest Therapeutics, Inc. (0%), greater than Lexaria Bioscience Corp. (-201.10%), less than Navidea Biopharmaceuticals, Inc. (0%), greater than ZyVersa Therapeutics, Inc. (-82.80%), greater than Biodexa Pharmaceuticals Plc (-173.56%), greater than Oncorus, Inc. (-172.51%), greater than null (-101.74%), greater than null (-130.61%),
Company | ROE | Market cap |
---|---|---|
0% | $1.44K | |
13.30% | $81.41K | |
27.88% | $2.31M | |
-87.48% | $6.14M | |
-58.37% | $377.63K | |
16.82% | $7.19M | |
93.13% | $2.96M | |
-398.33% | $175.37M | |
-194.17% | $30.70M | |
-13.69% | $4.26K | |
0% | $25.00M | |
-201.10% | $39.79M | |
0% | $50.04K | |
-82.80% | $1.96M | |
-173.56% | $3.30M | |
-172.51% | $3.14M | |
-101.74% | $0 | |
-130.61% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theralink Technologies, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Theralink Technologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Theralink Technologies, Inc.'s ROE?
How is the ROE calculated for Theralink Technologies, Inc. (THER)?
What is the highest ROE for Theralink Technologies, Inc. (THER)?
What is the 3-year average ROE for Theralink Technologies, Inc. (THER)?
What is the 5-year average ROE for Theralink Technologies, Inc. (THER)?
How does the current ROE for Theralink Technologies, Inc. (THER) compare to its historical average?